Healthcare - Biotechnology - NASDAQ - US
$ 26.64
-9.6 %
$ 2.3 B
Market Cap
-11.43
P/E
INCOME STATEMENT
23.4 M
REVENUE
-134 M
OPERATING INCOME
-113 M
NET INCOME
EFFICIENCY
Earnings Waterfall
IDEAYA Biosciences, Inc.
| Revenue | 23.4 M |
| Cost Of Revenue | 130 M |
| Gross Profit | -106 M |
| Operating Expenses | 158 M |
| Operating Income | -134 M |
| Other Expenses | -21.5 M |
| Net Income | -113 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | |
|---|---|---|---|---|---|---|---|
| REVENUE | |||||||
| Revenue | 23.4 | 50.9 | 27.9 | 19.5 | 0 | 0 | 0 |
| GROSS PROFIT | |||||||
| Cost Of Revenue | 129.5 | 2.1 | 1.7 | 39.7 | 1.2 | 0.9 | 0.4 |
| Gross Profit | (106.1) | 48.8 | 26.2 | (20.2) | (1.2) | (0.9) | (0.4) |
| OPERATING INCOME | |||||||
| Operating Expenses | 157.8 | 113.4 | 78.2 | 54.9 | 44.3 | 36.4 | 14.4 |
| Selling, General and Administrative Expenses | 28.3 | 23.9 | 20.1 | 15.2 | 10.0 | 4.7 | 2.1 |
| Research and Development Expenses | 129.5 | 89.5 | 58.2 | 39.7 | 34.3 | 31.7 | 12.4 |
| Operating Income | (134.4) | (62.5) | (50.3) | (35.3) | (44.3) | (36.4) | (14.4) |
| PRE-TAX INCOME | |||||||
| Interest Income Expense | 0 | 3.8 | 0 | 0.8 | 0 | 0 | 0 |
| Total Other Income | 21.5 | 3.8 | 0.5 | 0.8 | 2.3 | 2.1 | 2.6 |
| Pre-Tax Income | (113.0) | (58.7) | (49.8) | (34.5) | (42.0) | (34.3) | (11.9) |
| NET INCOME | |||||||
| Tax Provision | 0 | (3.8) | (2.2) | (2.2) | (3.5) | 2.1 | (0.1) |
| Net Income | (113.0) | (54.8) | (47.5) | (32.3) | (38.4) | (34.3) | (11.9) |
| EPS | 1.96 | 1.32 | 1.35 | 1.31 | 1.9 | 2.41 | 0.83 |